Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank Disease ID
1 African trypanosomiasis 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
2 African trypanosomiasis 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
3 African trypanosomiasis 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
4 African trypanosomiasis 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
5 African trypanosomiasis 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
6 AGE-RAGE signaling pathway in diabetic complications 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
7 AGE-RAGE signaling pathway in diabetic complications 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
8 AGE-RAGE signaling pathway in diabetic complications 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
9 AGE-RAGE signaling pathway in diabetic complications 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
10 AGE-RAGE signaling pathway in diabetic complications 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
11 Alcoholic liver disease 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
12 Alcoholic liver disease 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
13 Alcoholic liver disease 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
14 Alcoholic liver disease 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
15 Alcoholic liver disease 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
16 Alzheimer disease 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
17 Alzheimer disease 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
18 Alzheimer disease 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
19 Alzheimer disease 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
20 Alzheimer disease 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
21 Amoebiasis 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
22 Amoebiasis 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
23 Amoebiasis 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
24 Amoebiasis 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
25 Amoebiasis 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
26 C-type lectin receptor signaling pathway 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
27 C-type lectin receptor signaling pathway 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
28 C-type lectin receptor signaling pathway 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
29 C-type lectin receptor signaling pathway 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
30 C-type lectin receptor signaling pathway 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
31 Cellular senescence 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
32 Cellular senescence 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
33 Cellular senescence 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
34 Cellular senescence 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
35 Cellular senescence 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
36 Chagas disease 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
37 Chagas disease 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
38 Chagas disease 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
39 Chagas disease 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
40 Chagas disease 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
41 Coronavirus disease - COVID-19 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
42 Coronavirus disease - COVID-19 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
43 Coronavirus disease - COVID-19 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
44 Coronavirus disease - COVID-19 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
45 Coronavirus disease - COVID-19 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
46 Coronavirus disease - COVID-19 💬
[1] IL6R 💬 Sarilumab 💬 Sarilumab [5] 41, 46, 84, 107, 271 💬
47 Coronavirus disease - COVID-19 💬
[1] IL6R 💬 Satralizumab 💬 Satralizumab [4] 11, 13, 86, 113 💬
48 Coronavirus disease - COVID-19 💬
[1] IL6R 💬 Tocilizumab 💬 Tocilizumab [24]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬
49 Cytokine-cytokine receptor interaction 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
50 Cytokine-cytokine receptor interaction 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
51 Cytokine-cytokine receptor interaction 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
52 Cytokine-cytokine receptor interaction 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
53 Cytokine-cytokine receptor interaction 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
54 Cytokine-cytokine receptor interaction 💬
[1] IL6R 💬 Sarilumab 💬 Sarilumab [5] 41, 46, 84, 107, 271 💬
55 Cytokine-cytokine receptor interaction 💬
[1] IL6R 💬 Satralizumab 💬 Satralizumab [4] 11, 13, 86, 113 💬
56 Cytokine-cytokine receptor interaction 💬
[1] IL6R 💬 Tocilizumab 💬 Tocilizumab [24]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬
57 Cytosolic DNA-sensing pathway 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
58 Cytosolic DNA-sensing pathway 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
59 Cytosolic DNA-sensing pathway 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
60 Cytosolic DNA-sensing pathway 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
61 Cytosolic DNA-sensing pathway 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
62 Epstein-Barr virus infection 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
63 Epstein-Barr virus infection 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
64 Epstein-Barr virus infection 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
65 Epstein-Barr virus infection 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
66 Epstein-Barr virus infection 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
67 FoxO signaling pathway 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
68 FoxO signaling pathway 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
69 FoxO signaling pathway 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
70 FoxO signaling pathway 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
71 FoxO signaling pathway 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
72 Graft-versus-host disease 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
73 Graft-versus-host disease 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
74 Graft-versus-host disease 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
75 Graft-versus-host disease 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
76 Graft-versus-host disease 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
77 Hematopoietic cell lineage 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
78 Hematopoietic cell lineage 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
79 Hematopoietic cell lineage 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
80 Hematopoietic cell lineage 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
81 Hematopoietic cell lineage 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
82 Hematopoietic cell lineage 💬
[1] IL6R 💬 Sarilumab 💬 Sarilumab [5] 41, 46, 84, 107, 271 💬
83 Hematopoietic cell lineage 💬
[1] IL6R 💬 Satralizumab 💬 Satralizumab [4] 11, 13, 86, 113 💬
84 Hematopoietic cell lineage 💬
[1] IL6R 💬 Tocilizumab 💬 Tocilizumab [24]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬
85 Hepatitis B 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
86 Hepatitis B 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
87 Hepatitis B 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
88 Hepatitis B 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
89 Hepatitis B 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
90 Herpes simplex virus 1 infection 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
91 Herpes simplex virus 1 infection 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
92 Herpes simplex virus 1 infection 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
93 Herpes simplex virus 1 infection 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
94 Herpes simplex virus 1 infection 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
95 HIF-1 signaling pathway 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
96 HIF-1 signaling pathway 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
97 HIF-1 signaling pathway 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
98 HIF-1 signaling pathway 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
99 HIF-1 signaling pathway 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
100 HIF-1 signaling pathway 💬
[1] IL6R 💬 Sarilumab 💬 Sarilumab [5] 41, 46, 84, 107, 271 💬
101 HIF-1 signaling pathway 💬
[1] IL6R 💬 Satralizumab 💬 Satralizumab [4] 11, 13, 86, 113 💬
102 HIF-1 signaling pathway 💬
[1] IL6R 💬 Tocilizumab 💬 Tocilizumab [24]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬
103 Human cytomegalovirus infection 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
104 Human cytomegalovirus infection 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
105 Human cytomegalovirus infection 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
106 Human cytomegalovirus infection 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
107 Human cytomegalovirus infection 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
108 Human cytomegalovirus infection 💬
[1] IL6R 💬 Sarilumab 💬 Sarilumab [5] 41, 46, 84, 107, 271 💬
109 Human cytomegalovirus infection 💬
[1] IL6R 💬 Satralizumab 💬 Satralizumab [4] 11, 13, 86, 113 💬
110 Human cytomegalovirus infection 💬
[1] IL6R 💬 Tocilizumab 💬 Tocilizumab [24]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬
111 Human T-cell leukemia virus 1 infection 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
112 Human T-cell leukemia virus 1 infection 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
113 Human T-cell leukemia virus 1 infection 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
114 Human T-cell leukemia virus 1 infection 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
115 Human T-cell leukemia virus 1 infection 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
116 Hypertrophic cardiomyopathy 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
117 Hypertrophic cardiomyopathy 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
118 Hypertrophic cardiomyopathy 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
119 Hypertrophic cardiomyopathy 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
120 Hypertrophic cardiomyopathy 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
121 IL-17 signaling pathway 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
122 IL-17 signaling pathway 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
123 IL-17 signaling pathway 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
124 IL-17 signaling pathway 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
125 IL-17 signaling pathway 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
126 Inflammatory bowel disease 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
127 Inflammatory bowel disease 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
128 Inflammatory bowel disease 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
129 Inflammatory bowel disease 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
130 Inflammatory bowel disease 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
131 Influenza A 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
132 Influenza A 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
133 Influenza A 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
134 Influenza A 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
135 Influenza A 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
136 Insulin resistance 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
137 Insulin resistance 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
138 Insulin resistance 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
139 Insulin resistance 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
140 Insulin resistance 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
141 Intestinal immune network for IgA production 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
142 Intestinal immune network for IgA production 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
143 Intestinal immune network for IgA production 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
144 Intestinal immune network for IgA production 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
145 Intestinal immune network for IgA production 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
146 JAK-STAT signaling pathway 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
147 JAK-STAT signaling pathway 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
148 JAK-STAT signaling pathway 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
149 JAK-STAT signaling pathway 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
150 JAK-STAT signaling pathway 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
151 JAK-STAT signaling pathway 💬
[1] IL6R 💬 Sarilumab 💬 Sarilumab [5] 41, 46, 84, 107, 271 💬
152 JAK-STAT signaling pathway 💬
[1] IL6R 💬 Satralizumab 💬 Satralizumab [4] 11, 13, 86, 113 💬
153 JAK-STAT signaling pathway 💬
[1] IL6R 💬 Tocilizumab 💬 Tocilizumab [24]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬
154 Kaposi sarcoma-associated herpesvirus infection 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
155 Kaposi sarcoma-associated herpesvirus infection 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
156 Kaposi sarcoma-associated herpesvirus infection 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
157 Kaposi sarcoma-associated herpesvirus infection 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
158 Kaposi sarcoma-associated herpesvirus infection 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
159 Legionellosis 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
160 Legionellosis 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
161 Legionellosis 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
162 Legionellosis 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
163 Legionellosis 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
164 Lipid and atherosclerosis 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
165 Lipid and atherosclerosis 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
166 Lipid and atherosclerosis 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
167 Lipid and atherosclerosis 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
168 Lipid and atherosclerosis 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
169 Malaria 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
170 Malaria 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
171 Malaria 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
172 Malaria 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
173 Malaria 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
174 Measles 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
175 Measles 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
176 Measles 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
177 Measles 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
178 Measles 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
179 NOD-like receptor signaling pathway 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
180 NOD-like receptor signaling pathway 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
181 NOD-like receptor signaling pathway 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
182 NOD-like receptor signaling pathway 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
183 NOD-like receptor signaling pathway 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
184 Non-alcoholic fatty liver disease 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
185 Non-alcoholic fatty liver disease 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
186 Non-alcoholic fatty liver disease 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
187 Non-alcoholic fatty liver disease 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
188 Non-alcoholic fatty liver disease 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
189 Non-alcoholic fatty liver disease 💬
[1] IL6R 💬 Sarilumab 💬 Sarilumab [5] 41, 46, 84, 107, 271 💬
190 Non-alcoholic fatty liver disease 💬
[1] IL6R 💬 Satralizumab 💬 Satralizumab [4] 11, 13, 86, 113 💬
191 Non-alcoholic fatty liver disease 💬
[1] IL6R 💬 Tocilizumab 💬 Tocilizumab [24]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬
192 Pathogenic Escherichia coli infection 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
193 Pathogenic Escherichia coli infection 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
194 Pathogenic Escherichia coli infection 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
195 Pathogenic Escherichia coli infection 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
196 Pathogenic Escherichia coli infection 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
197 Pathways in cancer 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
198 Pathways in cancer 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
199 Pathways in cancer 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
200 Pathways in cancer 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
201 Pathways in cancer 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
202 Pathways in cancer 💬
[1] IL6R 💬 Sarilumab 💬 Sarilumab [5] 41, 46, 84, 107, 271 💬
203 Pathways in cancer 💬
[1] IL6R 💬 Satralizumab 💬 Satralizumab [4] 11, 13, 86, 113 💬
204 Pathways in cancer 💬
[1] IL6R 💬 Tocilizumab 💬 Tocilizumab [24]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬
205 Pathways of neurodegeneration - multiple diseases 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
206 Pathways of neurodegeneration - multiple diseases 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
207 Pathways of neurodegeneration - multiple diseases 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
208 Pathways of neurodegeneration - multiple diseases 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
209 Pathways of neurodegeneration - multiple diseases 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
210 Pertussis 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
211 Pertussis 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
212 Pertussis 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
213 Pertussis 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
214 Pertussis 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
215 PI3K-Akt signaling pathway 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
216 PI3K-Akt signaling pathway 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
217 PI3K-Akt signaling pathway 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
218 PI3K-Akt signaling pathway 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
219 PI3K-Akt signaling pathway 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
220 PI3K-Akt signaling pathway 💬
[1] IL6R 💬 Sarilumab 💬 Sarilumab [5] 41, 46, 84, 107, 271 💬
221 PI3K-Akt signaling pathway 💬
[1] IL6R 💬 Satralizumab 💬 Satralizumab [4] 11, 13, 86, 113 💬
222 PI3K-Akt signaling pathway 💬
[1] IL6R 💬 Tocilizumab 💬 Tocilizumab [24]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬
223 Prion disease 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
224 Prion disease 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
225 Prion disease 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
226 Prion disease 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
227 Prion disease 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
228 Rheumatoid arthritis 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
229 Rheumatoid arthritis 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
230 Rheumatoid arthritis 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
231 Rheumatoid arthritis 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
232 Rheumatoid arthritis 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
233 Salmonella infection 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
234 Salmonella infection 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
235 Salmonella infection 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
236 Salmonella infection 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
237 Salmonella infection 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
238 Th17 cell differentiation 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
239 Th17 cell differentiation 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
240 Th17 cell differentiation 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
241 Th17 cell differentiation 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
242 Th17 cell differentiation 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
243 Th17 cell differentiation 💬
[1] IL6R 💬 Sarilumab 💬 Sarilumab [5] 41, 46, 84, 107, 271 💬
244 Th17 cell differentiation 💬
[1] IL6R 💬 Satralizumab 💬 Satralizumab [4] 11, 13, 86, 113 💬
245 Th17 cell differentiation 💬
[1] IL6R 💬 Tocilizumab 💬 Tocilizumab [24]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬
246 TNF signaling pathway 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
247 TNF signaling pathway 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
248 TNF signaling pathway 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
249 TNF signaling pathway 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
250 TNF signaling pathway 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
251 Toll-like receptor signaling pathway 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
252 Toll-like receptor signaling pathway 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
253 Toll-like receptor signaling pathway 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
254 Toll-like receptor signaling pathway 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
255 Toll-like receptor signaling pathway 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
256 Transcriptional misregulation in cancer 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
257 Transcriptional misregulation in cancer 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
258 Transcriptional misregulation in cancer 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
259 Transcriptional misregulation in cancer 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
260 Transcriptional misregulation in cancer 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
261 Tuberculosis 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
262 Tuberculosis 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
263 Tuberculosis 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
264 Tuberculosis 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
265 Tuberculosis 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
266 Viral protein interaction with cytokine and cytokine receptor 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
267 Viral protein interaction with cytokine and cytokine receptor 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
268 Viral protein interaction with cytokine and cytokine receptor 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
269 Viral protein interaction with cytokine and cytokine receptor 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
270 Viral protein interaction with cytokine and cytokine receptor 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬
271 Viral protein interaction with cytokine and cytokine receptor 💬
[1] IL6R 💬 Sarilumab 💬 Sarilumab [5] 41, 46, 84, 107, 271 💬
272 Viral protein interaction with cytokine and cytokine receptor 💬
[1] IL6R 💬 Satralizumab 💬 Satralizumab [4] 11, 13, 86, 113 💬
273 Viral protein interaction with cytokine and cytokine receptor 💬
[1] IL6R 💬 Tocilizumab 💬 Tocilizumab [24]  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬
274 Yersinia infection 💬
[1] IL6 💬 Olokizumab 💬 Olokizumab [2] 46, 96 💬
275 Yersinia infection 💬
[1] IL6 💬 Pirfenidone 💬 Pirfenidone [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
276 Yersinia infection 💬
[1] IL6 💬 Pomalidomide 💬 Pomalidomide [6] 28, 34, 51, 85, 227, 331 💬
277 Yersinia infection 💬
[1] IL6 💬 Siltuximab 💬 Siltuximab [2] 28, 331 💬
278 Yersinia infection 💬
[1] IL6 💬 Sirukumab 💬 Sirukumab [2] 41, 46 💬